Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy

Transfusion. 2007 Apr;47(4):749-51. doi: 10.1111/j.1537-2995.2007.01182.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Blood Coagulation Disorders / complications
  • Blood Coagulation Disorders / therapy*
  • Blood Component Transfusion / adverse effects
  • Blood Component Transfusion / methods*
  • Dose-Response Relationship, Drug
  • Factor VII / administration & dosage
  • Factor VII / therapeutic use*
  • Factor VIIa / administration & dosage
  • Factor VIIa / therapeutic use*
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control
  • Humans
  • International Normalized Ratio
  • Middle Aged
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Wounds and Injuries / complications
  • Wounds and Injuries / therapy

Substances

  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa